WPRIM Management System> DCMS> Journal of Clinical Hepatology> 2023> 39> 12

Volume: 39 Issue: 12

1. The diagnosis and treatment of pancreatic disease-related dyspepsia Page:2753—2756
2. Advances in the diagnosis and treatment of dyspepsia in chronic pancreatitis patients Page:2757—2762
3. Current status of the diagnosis and treatment of pancreatic exocrine insufficiency after pancreatectomy Page:2763—2769
4. Diagnosis and treatment of dyspepsia associated with pancreatic tumors Page:2770—2774
5. Expert consensus on Traditional Chinese Medicine diagnosis and treatment of ascites due to cirrhosis （2023） Page:2775—2781
6. Chinese expert consensus on Co-Ablation System for the treatment of primary liver cancer （2023 edition） Page:2793—2797
7. Key points in hepatitis C guidance 2023 update： American Association for the Study of Liver Diseases-Infectious Diseases Society of America recommendations for testing， managing， and treating hepatitis C virus infection Page:2798—2803
8. Key points in pancreatic cancer： ESMO clinical practice guideline for diagnosis， treatment and follow-up （2023） Page:2804—2808
9. Predictors of HBsAg clearance in HBeAg-negative chronic hepatitis B patients treated with pegylated interferon α-2b and the construction of a nomogram model Page:2809—2816
10. Effect of depression on response to ursodeoxycholic acid and the occurrence of liver cirrhosis in patients with primary biliary cholangitis Page:2817—2823
11. Association between spontaneous portosystemic shunt and hepatorenal syndrome in liver cirrhosis Page:2824—2830
12. Clinical features of bone mass loss in liver cirrhosis and its association with sarcopenia Page:2831—2838
13. Value of Model for End-Stage Liver Disease score and albumin-bilirubin score combined with β2-microglobulin in predicting liver cirrhosis with acute kidney injury Page:2839—2844
14. Mechanism of microRNA-223-3p inhibiting hepatic stellate cell activation by targeting microtubule-associated protein 1B Page:2845—2850
15. Efficacy of human umbilical cord mesenchymal stem cells via different transplantation approaches in treatment of rats with liver cirrhosis Page:2851—2857
16. Role of HBV DNA polymerase in mediating the immune escape of tumor cells in HBV-related hepatocellular carcinoma Page:2858—2866
17. Value of the serum levels of Clusterin and sphingosine 1-phosphate in assessing the prognosis of sepsis patients with acute liver injury Page:2867—2872
18. Protective effect of Zhizi Dahuang decoction in a mouse model of alcoholic liver disease Page:2873—2884
19. Efficacy and safety of endoscopic retrograde cholangiopancreatography during pregnancy and puerperium： A comparative analysis Page:2885—2893
20. Establishment of a prognostic prediction model for pancreatic cancer based on endoplasmic reticulum stress-related genes Page:2894—2900
21. Application of Mengchao Liver Disease-Brain System version 2.0 in artificial intelligence-assisted clinical diagnosis and treatment： A preliminary study Page:2901—2907
22. Theory and practice of immunoregulatory therapy with traditional Chinese medicine for chronic hepatitis B Page:2908—2913
23. Research advances in lean nonalcoholic fatty liver disease Page:2914—2919
24. Research advances in mesenchymal stem cells and their exosomes in treatment of autoimmune hepatitis Page:2920—2925
25. Role of T lymphocytes in primary sclerosing cholangitis Page:2926—2931
26. Research advances in signaling pathways associated with potential anti-liver fibrosis drugs and targets Page:2932—2941
27. Thoughts on the diagnosis and treatment of hepatic encephalopathy associated with blood ammonia in liver cirrhosis Page:2942—2945
28. Mechanism of action of N7-methylguanosine in hepatocellular carcinoma Page:2946—2951
29. Regulatory role of mechanical forces in the formation of liver organoids Page:2952—2958
30. Evaluation of cholestatic liver disease animal model based on clinical syndrome characteristics of integrated traditional Chinese and Western medicine Page:2959—2964
31. Research advances in targeted therapy for gallbladder carcinoma Page:2965—2969
32. Changes in intestinal microbiota and application of probiotics in patients with acute pancreatitis Page:2970—2977
33. Research advances in machine learning models for acute pancreatitis Page:2978—2984

©2019 - Present World Health Organization Regional Office for the Western Pacific. All Rights Reserved.